Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirina C for Common Cold
NCT01033526Phase 4Completed
- Sponsor
- Bayer
- Start
- Oct 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in common cold comparing Aspirin + Ascorbic Acid with Placebo (2 arms). Primary endpoint: Change in Cold Symptoms (WURSS domain 2 score) at 2 hours. Started Oct 2005; status: completed.
02
Drugs
aspirin
03
Conditions
common cold
Beyond the preview
Go deeper on NCT01033526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01033526.